MRK
66
3
VMC
57
3
EXPE
66
2
OMC
53
3
F
42
-4
SWN
30
-12
FTI
76
2
ECL
84
14
AKAM
48
-11
RIG
28
2
SLG
71
-4
EW
40
2
UNP
50
4
PDCO
57
2
TRV
43
-3
PYPL
39
4
HST
40
2
HSIC
44
4
WHR
57
2
INTU
69
4
MRK
66
3
VMC
57
3
EXPE
66
2
OMC
53
3
F
42
-4
SWN
30
-12
FTI
76
2
ECL
84
14
AKAM
48
-11
RIG
28
2
SLG
71
-4
EW
40
2
UNP
50
4
PDCO
57
2
TRV
43
-3
PYPL
39
4
HST
40
2
HSIC
44
4
WHR
57
2
INTU
69
4
Financhill
Back

Kura Sushi USA Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
54

KRUS
Kura Sushi USA

Last Price:
88.15
Seasonality Move:
22.84%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Buy
54
Kura Sushi USA (KRUS) is a Buy

Is Kura Sushi USA a Buy, Sell or Hold?

  • The current Kura Sushi USA [KRUS] share price is $87.72. The Score for KRUS is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • KRUS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KRUS Stock Price Chart

What is Kura Sushi USA's stock price today?

  • The Kura Sushi USA share price today is $87.72
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KRUS is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

KRUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.81 Sell
Relative Strength Index (14 RSI): 41.09 Sell
Chaikin Money Flow: 9801 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (85.85 - 102.97) Sell
Bollinger Bands (100): (93.49 - 110.49) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

KRUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 85.02 Buy
20-day SMA: 91.62 Sell
50-day SMA: 101.5 Sell
200-day SMA: 86.39 Buy
8-day EMA: 87.1 Buy
20-day EMA: 91.33 Sell
50-day EMA: 97.3 Sell
200-day EMA: 91.37 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Kura Sushi USA Earnings Growth & KRUS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.45 per share, an increase this year of $0.12 per share, and an increase next year of $0.40 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Kura Sushi USA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):